WHITE PAPER | SEP 03, 2026

Digital Twins for Clinical Trial Protocols: from Protocol Design to Predictive Study Execution

A growing generation of AI-enabled digital twin approaches offers a new path. Instead of treating the protocol as a static document, organizations can model it as a dynamic system, whose likely operational consequences scan be simulated prior to study execution.

Citeline may contact you about relevant products, services, and content. To opt out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.

Related resources

A gloved hand holds a small red and white pill against a high-tech blue background filled with digital interfaces, AI data visualizations, and a DNA helix.
JUL 08, 2026
Article
Clinical

How AI Has Revolutionized Clinical Development

Suzanne Caruso, President of Clinical, Regulatory, and Strategic Intelligence, discussed AI in clinical trials on the Drug Discovery World podcast, which covers drug discovery and development, pharma, and biotech.

''
MAR 18, 2026
White paper
Clinical

AI in Pharma 2026: From Insight to Execution in Clinical Trials

Artificial intelligence (AI) is reshaping clinical trials. AI can process both structured and unstructured multimodal data, making it a powerful enabler for R&D. Multiple AI use cases have been identified across all clinical development functions.

''
FEB 26, 2026
Use Case
Clinical

Winning at Clinical Feasibility: How Citeline’s AI-powered Solutions Change the Game

This use case illustrates how a sponsor can rely on Citeline's AI-powered solutions to plan a Phase II clinical trial. The sponsor benchmarks trial feasibility, identifies viable sites and investigators, and predicts recruitment success.